Question 1

What is the catalog number for Modified semi-solid Rappaport-Vassiliadis (MSRV - acc. to ISO 6579) 6 x 200 ml Bottles?

Accepted Answer

The catalog number for Modified semi-solid Rappaport-Vassiliadis (MSRV - acc. to ISO 6579) 6 x 200 ml Bottles is TMB_MSRV_F200_6.

Question 2

What sizes are available for Modified semi-solid Rappaport-Vassiliadis (MSRV - acc. to ISO 6579) 6 x 200 ml Bottles?

Accepted Answer

Modified semi-solid Rappaport-Vassiliadis (MSRV - acc. to ISO 6579) 6 x 200 ml Bottles is available in the following size(s): 6 x 200 mL Bottles.

Question 3

Is Modified semi-solid Rappaport-Vassiliadis (MSRV - acc. to ISO 6579) 6 x 200 ml Bottles in stock?

Accepted Answer

Modified semi-solid Rappaport-Vassiliadis (MSRV - acc. to ISO 6579) 6 x 200 ml Bottles is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 5

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Modified semi-solid Rappaport-Vassiliadis (MSRV - acc. to ISO 6579) 6 x 200 ml Bottles

Product Specifications

Frequently Asked Questions

Explore Other Products

Human IgG Immunoglobulin (IG266), CF647 conjugate, 0.1mg/mL

E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF568 conjugate, 0.1mg/mL

CD34 (ICO-115), CF740 conjugate, 0.1mg/mL

Cytokeratin, LMW (AE-1), CF488A conjugate, 0.1mg/mL

PSA (Prostate Specific Antigen) (A67-B/E3), CF647 conjugate, 0.1mg/mL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), 0.2mg/mL